Excipients Drafting Group
The Excipients Drafting Group (ExcpDG) was set up by the Committee for Medicinal Products for Human Use (CHMP) to revise the European Commision's guideline on 'Excipients in the label and package leaflet of medicinal products for human use' (CHMP/463/00) and its annex.
The objective of the ExcpDG is to update the labelling of selected excipients listed in the annex of the guideline, as well as to add new excipients to the list. For more information, see Product information: Excipients labelling.
Mandate, rules of procedure and work programme
For more information on the ExcpDG's responsibilities and composition, see:
- Mandate, objectives and rules of procedure for the temporary working parties and drafting groups
- Work plan 2018
Update: In 2019, EMA is temporarily suspending or scaling back certain activities due to Brexit. For more information, see EMA’s business continuity plan.
The ExcpDG is a multidisciplinary drafting group composed of European expert selected from or associated with the national agencies with non-clinical, clinical and quality expertise, representing relevant working parties or committees of the Agency. Nominations for members are adopted by the CHMP.
Below (in alphabetical order of surname) are the current members of the ExcpDG. The members' declarations of interests are available in the list of European experts.
CHMP sponsor: Jean-Louis Robert
- Akosua Adjei
- Brian Aylward
- Dominique Masset (Chair)
- Anthony Nunn
- Laivi Saaremäel (Vice-Chair)
- Ann Marie Totterman
- Diana van Riet-Nales
- Karin Weisser